Aerogen CEO Awarded Europe’s Top Entrepreneurial Accolade

Aerogen awarded prestigious European Entrepreneur of the Year Award

GALWAY, Ireland--()--John Power, CEO of Aerogen, a global leader in aerosol drug delivery, has been named European Entrepreneur of the Year at the prestigious 2016 RSM Awards in Milan.

Recognised as Europe’s largest and most significant cross-sector business recognition programme, John Power, and Aerogen was chosen to receive the award having been shortlisted from 32,000 companies across 33 countries.

Now in its third year, the European Entrepreneur of the Year accolade was awarded in recognition of Power’s exceptional vision and leadership in the establishment and development of the company. Aerogen technologies are today used to treat patients in over 70 countries around the world and over 3 million patients have benefited from their unique products.

Aerogen technology is deployed extensively across Europe and the US where is it used in 60% of the top 100 hospitals. Aerogen’s patented palladium vibrating mesh technology lies at the heart of its market leading aerosol drug delivery systems.

On accepting the award John said “I am proud to accept this award on behalf of the entire Aerogen team. It is their dedication and that of the care givers around the world who use our products to treat the most critically ill patients that has resulted in this success.

Aerogen strives for excellence in everything we do. We work hand in hand with the respiratory professionals at all levels and this reward is a great reminder of the work that we continue to do to deliver the best possible patient care.”

Participants in the RSM awards represented a combined turnover of over €1.2 trillion Euros and employ over 2.7 million people. Ireland was well represented in the European Final, making up almost 10% of the finalists in Europe’s biggest business competition.

ENDS

Contacts

For Aerogen
Sarah McDonagh
aerogen@humebrophy.com
+353 (0) 86 778 0301

Contacts

For Aerogen
Sarah McDonagh
aerogen@humebrophy.com
+353 (0) 86 778 0301